Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q2 2025 Earnings Call Transcript August 6, 2025
Mirum Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.31.
Operator: Hello, everyone, and welcome to the Mirum Pharmaceuticals Report Second Quarter 2025 Financial Results and provide Business Update. My name is Carla, and I will be coordinating your call today. [Operator Instructions]. I would now like to hand you over to your host, Andrew McKibben, SVP...
